Methenamine Hippurate (Aurobindo Pharma Limited)


Welcome to the PulseAid listing for the Methenamine Hippurate drug offered from Aurobindo Pharma Limited. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aurobindo Pharma Limited
NON-PROPRIETARY NAME: Methenamine Hippurate
SUBSTANCE NAME: METHENAMINE HIPPURATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-07-05
END MARKETING DATE: 0000-00-00


Methenamine Hippurate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMethenamine Hippurate from Aurobindo Pharma Limited
LABELER NAME: Aurobindo Pharma Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/1)
START MARKETING DATE: 2016-07-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65862-782_9f002ad9-58e7-44f2-a980-3cc3f36bbd9b
PRODUCT NDC: 65862-782
APPLICATION NUMBER: ANDA205661

Other METHENAMINE HIPPURATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Methenamine Hippurate
Aurobindo Pharma LimitedMethenamine Hippurate
Carilion Materials ManagementMethenamine Hippurate
CorePharma, LLCMethenamine Hippurate
County Line Pharmaceuticals, LLCMethenamine Hippurate
Leading Pharma, LLCMethenamine Hippurate
Sanofi-Aventis U.S. LLCHiprex
Validus Pharmaceuticals LLCHIPREX
Winthrop U.S.Methenamine Hippurate